| # | Drug | Count |
|---|---|---|
| 0 | ATEZOLIZUMAB | 22 |
| 1 | BEVACIZUMAB | 22 |
| 2 | SORAFENIB | 8 |
| 3 | ETANERCEPT | 7 |
| 4 | CISPLATIN | 6 |
| 5 | GEMCITABINE | 6 |
| 6 | GEMCITABINE HYDROCHLORIDE | 6 |
| 7 | ADALIMUMAB | 5 |
| 8 | SPIRONOLACTONE | 5 |
| 9 | LENVATINIB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROCHLORPERAZINE EDISYLATE | 1 | 0.0008 |
| 1 | ATEZOLIZUMAB | 22 | 0.0006 |
| 2 | SORAFENIB | 8 | 0.0004 |
| 3 | CALCIUM POLYCARBOPHIL | 1 | 0.0003 |
| 4 | CEFIXIME | 1 | 0.0003 |
| 5 | REGORAFENIB | 3 | 0.0003 |
| 6 | OLAPARIB | 4 | 0.0002 |
| 7 | BEVACIZUMAB | 22 | 0.0002 |
| 8 | LENVATINIB | 4 | 0.0001 |
| 9 | MERCAPTOPURINE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 22 | 0.0002 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 4 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 22 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 4 | 0.0001 |
| 5 | Estrogen Receptor Antagonist [EPC] | 2 | 0.0000 |
| 6 | Bile Acid [EPC] | 1 | 0.0000 |
| 7 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Aldosterone Antagonist [EPC] | 5 | 0.0000 |
| 9 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |